Health
Novel formulation could provide a better treatment for patients with prostate cancer – News-Medical.Net
A novel formulation of the prostate cancer drug abiraterone acetate – currently marketed as Zytiga – will dramatically improve the quality of life for people suffering from prostate cancer, as pre-clinical trials by the University of South Australia show the …
Reviewed by Emily Henderson, B.Sc.Jun 20 2020
A novel formulation of the prostate cancer drug abiraterone acetate – currently marketed as Zytiga – will dramatically improve the quality of life for p…
Continue Reading
-
General20 hours agoJapan vs Wallabies Test live updates — blog, scores and stats from Tokyo
-
General24 hours agoBoy dies in foyer of Queensland police station after crash at Ormeau
-
Noosa News24 hours agoBoy, 3, dies in foyer of police station after crash
-
Noosa News24 hours agoStudy tracks how foxes ‘colonised’ Australia and grew to a population of 1.7 million